Ardine, M <br/><br/>
Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Aug 2006 
 - 1336-7 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdl045  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bone Density Conservation Agents--adverse effects<br/>Bone Neoplasms--drug therapy<br/>Breast Neoplasms--pathology<br/>Calcium--blood<br/>Diphosphonates--adverse effects<br/>Female<br/>Humans<br/>Jaw Diseases--chemically induced<br/>Middle Aged<br/>Osteonecrosis--chemically induced<br/>Parathyroid Hormone--blood